---
title: "EVERJOY HEALTH: Plans to repurchase shares for between 6 million and 10 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236551355.md"
description: "EVERJOY HEALTH announced plans to repurchase a portion of its issued ordinary shares in RMB, with the repurchase amount between RMB 6 million and RMB 10 million, and the repurchase price not exceeding RMB 5 per share. The expected number of shares to be repurchased is between 1.2 million and 2 million shares, accounting for 0.13% to 0.22% of the total share capital. The repurchase will be used for cancellation and reduction of the company's registered capital, with a duration of no more than 12 months from the date the plan is approved by the shareholders' meeting"
datetime: "2025-04-18T09:18:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236551355.md)
  - [en](https://longbridge.com/en/news/236551355.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236551355.md)
---

# EVERJOY HEALTH: Plans to repurchase shares for between 6 million and 10 million yuan

EVERJOY HEALTH announced that the company intends to use its own funds or self-raised funds to repurchase part of the issued ordinary shares of RMB through centralized bidding transactions. The repurchased shares will be fully used for cancellation and reduction of the company's registered capital. The total amount for the repurchase will not be less than 6 million yuan and not exceed 10 million yuan, with a repurchase price not exceeding 5 yuan per share. The estimated number of repurchased shares is approximately 1.2 million to 2 million shares, accounting for about 0.13% to 0.22% of the company's total share capital. The repurchase period will not exceed 12 months from the date the shareholders' meeting approves the repurchase plan

### Related Stocks

- [002162.CN](https://longbridge.com/en/quote/002162.CN.md)

## Related News & Research

- [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [TempraMed Announces Extension of Maccabi Healthcare Services Agreement | TMPTF Stock News](https://longbridge.com/en/news/296479419.md)
- [BUZZ-Faeth Therapeutics rises after FDA grants fast-track status for cancer drug](https://longbridge.com/en/news/296104768.md)
- [HELP Therapeutics Announces Nature Medicine Has Published HiCM-188 Clinical Trial Data for Advanced Ischemic Heart Failure](https://longbridge.com/en/news/296448083.md)